Skip to main content
FinSpry Logo
FinSpry
IKT logo
IKT
(NASDAQ)
Inhibikase Therapeutics, Inc.
$2.33-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Inhibikase Therapeutics (IKT) Stock Price & Financial Analysis

Inhibikase Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.12 - $2.34
52-Week High$2.36
52-Week Low$1.33
Open$2.13
Volume1.35M
Average Volume (3M)1.01M
Market Cap229.06M
Shares Outstanding98.31M
Price to Book (P/B)1.37
EV/EBITDA-3.33
50-Day MA$1.85
200-Day MA$1.75
52-Week Change17.68%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Inhibikase Therapeutics

What is the current stock price for IKT?

As of the latest trading session, IKT stock trades at $2.33. The 52-week range is $1.33–$2.36, with a day range of $2.12–$2.34.

What is the P/E ratio for IKT?

The P/E ratio (Price-to-Earnings) for IKT is shown in the Key Statistics section. This valuation metric helps compare Inhibikase Therapeutics, Inc. to industry peers.

Does IKT pay dividends?

Inhibikase Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IKT?

Based on 6 analysts, the consensus for IKT is Buy.

What is the market cap of IKT?

Inhibikase Therapeutics's market capitalization is $229.1M, classifying it as a micro-cap company. Inhibikase Therapeutics operates in the Healthcare sector within the Biotechnology industry.